BioForm Medical, Inc. (BFRM) Posts Q1 Loss of 1c, Beats Street by 6c; Guides FY10 Higher
BioForm Medical, Inc. (NASDAQ; BFRM) reports Q1 loss of $0.01, 6 cents better than the analyst estimate of ($0.07). Revenue for the quarter was $18.30 million, which compares to the estimate of $15.59 million.
Sees FY10 revs of $70 - $74 million, up from $64 - $70 million previously.
Stocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
